(Adds AstraZeneca reaction, background on Merck)

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service237 times read : Adjust font size: Decrease font Enlarge font
image

Reuters - LONDON/MUMBAI, Feb 7 (Reuters) - India's Ranbaxy Laboratories Ltd (RANB.BO: Quote , Profile , Research ) has tentative U.S. approval to sell a generic form of AstraZeneca Plc's (AZN.L: Quote , Profile , Research ) blockbuster heartburn and ulcer pill ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright